GLSI
Price
$8.41
Change
+$0.41 (+5.12%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
114.58M
83 days until earnings call
Intraday BUY SELL Signals
MAIA
Price
$1.12
Change
-$0.06 (-5.08%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
44.44M
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLSI vs MAIA

Header iconGLSI vs MAIA Comparison
Open Charts GLSI vs MAIABanner chart's image
Greenwich LifeSciences
Price$8.41
Change+$0.41 (+5.12%)
Volume$300
Capitalization114.58M
MAIA Biotechnology
Price$1.12
Change-$0.06 (-5.08%)
Volume$100
Capitalization44.44M
GLSI vs MAIA Comparison Chart in %
GLSI
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLSI vs. MAIA commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a StrongBuy and MAIA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (GLSI: $8.00 vs. MAIA: $1.17)
Brand notoriety: GLSI and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 37% vs. MAIA: 58%
Market capitalization -- GLSI: $114.58M vs. MAIA: $44.44M
GLSI [@Biotechnology] is valued at $114.58M. MAIA’s [@Biotechnology] market capitalization is $44.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLSI and MAIA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 4 TA indicator(s) are bullish while MAIA’s TA Score has 5 bullish TA indicator(s).

  • GLSI’s TA Score: 4 bullish, 4 bearish.
  • MAIA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MAIA is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -4.76% price change this week, while MAIA (@Biotechnology) price change was +20.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

GLSI is expected to report earnings on Feb 25, 2026.

MAIA is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($115M) has a higher market cap than MAIA($44.4M). GLSI YTD gains are higher at: -28.762 vs. MAIA (-40.909). GLSI has higher annual earnings (EBITDA): -18.14M vs. MAIA (-26.12M). MAIA has more cash in the bank: 10.1M vs. GLSI (3.13M). GLSI (0) and MAIA (0) have equivalent revenues.
GLSIMAIAGLSI / MAIA
Capitalization115M44.4M259%
EBITDA-18.14M-26.12M69%
Gain YTD-28.762-40.90970%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.13M10.1M31%
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
GLSIMAIA
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 6 days ago
89%
Momentum
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
87%
MACD
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
89%
Bullish Trend 6 days ago
89%
Aroon
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICCC4.980.24
+5.06%
ImmuCell Corp
NBHC37.510.05
+0.13%
NATIONAL BANK HOLDINGS Corp
TKCOF64.63N/A
N/A
Toho Co., Ltd.
CIGI142.81-0.05
-0.04%
Colliers International Group
CAPR6.34-0.31
-4.66%
Capricor Therapeutics

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with CRSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-2.91%
CRSP - GLSI
41%
Loosely correlated
-1.13%
MRNA - GLSI
38%
Loosely correlated
-0.41%
CELC - GLSI
37%
Loosely correlated
-1.01%
CRBU - GLSI
37%
Loosely correlated
-0.56%
RXRX - GLSI
37%
Loosely correlated
-0.69%
More

MAIA and

Correlation & Price change

A.I.dvisor tells us that MAIA and GLMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
-2.50%
GLMD - MAIA
32%
Poorly correlated
-1.47%
DNLI - MAIA
30%
Poorly correlated
-1.71%
IPSC - MAIA
30%
Poorly correlated
-2.62%
TPST - MAIA
29%
Poorly correlated
-0.98%
GLSI - MAIA
28%
Poorly correlated
-2.91%
More